EAN 2020 | Late-stage Parkinson’s disease: management strategies

Margherita Fabbri, MD, PhD, University of Toulouse, Toulouse, France, discusses what can be done for late-stage Parkinson’s disease patients in terms of adaptive tools, pharmacological and non-pharmacological therapeutics approaches. Dr Fabbri reveals that these patients are often not included in clinical trials. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).